| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
82,270,000 |
| Market
Cap: |
279.72(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$3.29 - $37.61 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : 8.1 |
| Insider 6 Months : 8.1 |
| Insider 3/6 Months : 16.7 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Revance Therapeutics is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. Co.'s segments are: Product, which refers to the business that includes the research, development and commercialization of its product candidates and the RHA® Collection of dermal fillers; and Service, which refers to the business that includes the development and commercialization of the OPUL™ Relational Commerce Platform and HintMD platform.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
30,000 |
30,000 |
30,000 |
30,000 |
| Total Buy Value |
$209,400 |
$209,400 |
$209,400 |
$209,400 |
| Total People Bought |
1 |
1 |
1 |
1 |
| Total Buy Transactions |
1 |
1 |
1 |
1 |
| Total Shares Sold |
29,089 |
29,089 |
295,146 |
446,160 |
| Total Sell Value |
$143,717 |
$143,717 |
$8,000,388 |
$12,719,522 |
| Total People Sold |
4 |
4 |
5 |
5 |
| Total Sell Transactions |
4 |
4 |
18 |
27 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Beraud Jill |
Director |
– • – |
2023-05-03 |
4 |
A |
$0.00 |
$0 |
D/D |
3,534 |
28,606 |
|
- |
|
| Nolet Chris |
Director |
– • – |
2023-05-03 |
4 |
A |
$0.00 |
$0 |
D/D |
3,534 |
28,606 |
|
- |
|
| Schilke Tobin |
CFO |
• – – |
2023-05-01 |
4 |
AS |
$31.70 |
$101,472 |
D/D |
(3,201) |
63,081 |
|
-52% |
|
| Schilke Tobin |
CFO |
• – – |
2023-03-15 |
4 |
D |
$30.65 |
$114,600 |
D/D |
(3,739) |
69,483 |
|
- |
|
| Sjuts Dustin S |
President |
• – – |
2023-03-15 |
4 |
D |
$30.65 |
$90,939 |
D/D |
(2,967) |
120,967 |
|
- |
|
| Foley Mark J |
CEO |
• • – |
2023-03-15 |
4 |
D |
$30.65 |
$163,702 |
D/D |
(5,341) |
818,010 |
|
- |
|
| Moxie Dwight |
SVP, GC & Secretary |
• – – |
2023-03-15 |
4 |
D |
$30.65 |
$224,665 |
D/D |
(7,330) |
48,217 |
|
- |
|
| Foley Mark J |
CEO |
• • – |
2023-03-09 |
4 |
S |
$31.59 |
$2,223,360 |
D/D |
(70,390) |
823,351 |
|
26% |
|
| Sjuts Dustin S |
President |
• – – |
2023-03-09 |
4 |
S |
$31.59 |
$679,358 |
D/D |
(21,508) |
123,934 |
|
26% |
|
| Moxie Dwight |
SVP, GC & Secretary |
• – – |
2023-03-09 |
4 |
S |
$31.59 |
$584,220 |
D/D |
(18,496) |
55,547 |
|
26% |
|
| Schilke Tobin |
CFO |
• – – |
2023-03-09 |
4 |
S |
$31.59 |
$584,884 |
D/D |
(18,517) |
73,222 |
|
26% |
|
| Coric Vlad |
Director |
– • – |
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
5,195 |
5,195 |
|
- |
|
| Schilke Tobin |
CFO |
• – – |
2023-03-01 |
4 |
AS |
$33.50 |
$107,234 |
D/D |
(3,201) |
49,390 |
|
-24% |
|
| Sjuts Dustin S |
President |
• – – |
2023-02-15 |
4 |
D |
$33.21 |
$91,859 |
D/D |
(2,766) |
93,046 |
|
- |
|
| Schilke Tobin |
CFO |
• – – |
2023-02-15 |
4 |
D |
$33.21 |
$69,243 |
D/D |
(2,085) |
52,591 |
|
- |
|
| Schilke Tobin |
CFO |
• – – |
2023-02-01 |
4 |
AS |
$34.60 |
$110,755 |
D/D |
(3,201) |
54,676 |
|
-14% |
|
| Schilke Tobin |
CFO |
• – – |
2023-01-20 |
4 |
AS |
$31.00 |
$31,000 |
D/D |
(1,000) |
57,877 |
|
-4% |
|
| Schilke Tobin |
CFO |
• – – |
2023-01-09 |
4 |
AS |
$25.00 |
$100,525 |
D/D |
(3,701) |
58,877 |
|
5% |
|
| Foley Mark J |
CEO |
• • – |
2022-12-31 |
4 |
A |
$12.18 |
$7,369 |
D/D |
605 |
718,092 |
|
- |
|
| Schilke Tobin |
CFO |
• – – |
2022-12-31 |
4 |
A |
$12.18 |
$7,856 |
D/D |
645 |
62,578 |
|
- |
|
| Sjuts Dustin S |
President |
• – – |
2022-12-31 |
4 |
A |
$12.18 |
$7,369 |
D/D |
605 |
95,812 |
|
- |
|
| Sjuts Dustin S |
President |
• – – |
2022-12-15 |
4 |
D |
$21.50 |
$62,694 |
D/D |
(2,916) |
95,207 |
|
- |
|
| Schilke Tobin |
CFO |
• – – |
2022-12-15 |
4 |
D |
$21.50 |
$33,476 |
D/D |
(1,557) |
61,933 |
|
- |
|
| Foley Mark J |
CEO |
• • – |
2022-10-13 |
4 |
D |
$26.97 |
$1,328,920 |
D/D |
(49,274) |
717,487 |
|
- |
|
| Foley Mark J |
CEO |
• • – |
2022-09-22 |
4 |
A |
$0.00 |
$0 |
D/D |
175,649 |
893,741 |
|
- |
|
415 Records found
|
|
Page 3 of 17 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.11 (3.34%) 
